Global Ophthalmic Viscoelastic Devices Market Size 2024, Forecast To 2033
6 Mar, 2024
The ophthalmic viscoelastic devices market size has grown steadily in recent years. It will grow from $2.61 billion in 2023 to $2.73 billion in 2024 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to rise in cataract surgeries, advancements in ophthalmic surgery techniques, aging population demographics, increased incidence of eye disorders, increased patient awareness and access to eye care. The ophthalmic viscoelastic devices market size is expected to see steady growth in the next few years. It will grow to $3.2 billion in 2028 at a compound annual growth rate (CAGR) of 4.0%. The growth in the forecast period can be attributed to technological refinements in device design, expanding applications in eye surgery, rising demand for premium intraocular lenses, global efforts in eye health and vision care, market penetration in emerging economies, collaborations and training programs in ophthalmology. Major trends in the forecast period include customized ophthalmic solutions, regulatory compliance and quality assurance, collaborations and partnerships, patient preference for premium products, continuous research and development.
Global Ophthalmic Viscoelastic Devices Market Key Driver
The surge in the prevalence of cataracts and glaucoma is expected to propel the growth of the ophthalmic viscoelastic devices market going forward. A cataract refers to clouding in the eyes with a decrease in vision. Glaucoma is a group of eye conditions that damage the optic nerve, often due to increased pressure inside the eye. It can result in vision loss and blindness if left untreated. An ophthalmic viscoelastic device (OVD) is a gel-like substance that is used during eye surgeries, including cataract surgery and certain glaucoma procedures. For instance, in January 2022, according to the National Library of Medicine, a US-based biomedical library operated by the federal government, 4.13 million adults over the age of 50 had moderate to severe vision impairment in 2020, and 3.6 million had glaucoma-related blindness. For people aged 50 and over, glaucoma was the primary cause of 11% of all cases of blindness worldwide in 2020. Furthermore, in October 2022, according to The BrightFocus Foundation, a US-based nonprofit organization, there were currently 80 million glaucoma sufferers globally, and by 2040, that figure was projected to rise to nearly 111 million. Therefore, the surge in the prevalence of cataracts and glaucoma is driving the growth of the ophthalmic viscoelastic devices market. The market size of the ophthalmic viscoelastic devices market in 2023 was [insert 2023 market size], and it is projected to reach [insert 2024 market size] by 2024 and [insert 2028 market size] by 2028.
Get A Free Sample Of The Global Ophthalmic Viscoelastic Devices Market ReportGlobal Ophthalmic Viscoelastic Devices Market Segments
The ophthalmic viscoelastic devices market covered in this report is segmented –
1) By Product Type: Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic
2) By Application: Cataract Surgery, Glaucoma Surgery, Corneal Transplant, Vitreoretinal Surgery
3) By End User: Hospital, Ophthalmology Clinics, Other End-Users
By Geography:The regions covered in the ophthalmic viscoelastic devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
North America was the largest region in the ophthalmic viscoelastic devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global ophthalmic viscoelastic devices market report during the forecast period. The regions covered in the ophthalmic viscoelastic devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Ophthalmic Viscoelastic Devices Industry Players
Altacor Ltd.,Bausch Health Companies Inc.,Bohus Biotech Ab,Carl Zeiss Meditec Ag,Cima Technology Inc.,Eyekon Medical Inc.,Haohai Biological Technology Co. Ltd.,Johnson & Johnson Pvt. Ltd.,Novartis International AG,Rumex International Corporation,Rayner Intraocular Lenses Limited,Aurolab,Ophtechnics Unlimited,Truviz Ophthalmic,Beye LLC,Alcon Inc.,Beaver Visitec Limited,Neu Micromed International Pvt. Ltd.,Abbott Medical Optics,Maxigen Biotech Inc.,Amring Pharmaceuticals Inc.,OcuCo Ltd.,Precision Lens Co. Ltd.,Croma Pharma GmbH,Medicontur Medical Engineering Ltd.,Rhein Medical Inc.,MicroSurgical Technology,FCI Ophthalmics Inc.,Hanita Lenses Ltd.,HOYA Medical Singapore Pte. Ltd.
Get The Full Global Ophthalmic Viscoelastic Devices Market Report
Ophthalmic Viscoelastic Devices Market Overview
An ophthalmic viscoelastic device (OVD) is a gel-like substance that is used during certain types of eye surgery to create and maintain space within the eye, protect delicate intraocular structures, and facilitate surgical maneuvers. OVDs are typically clear, viscous, and elastic, and they are designed to mimic the properties of the natural fluids inside the eye.
Ophthalmic Viscoelastic Devices Global Market Report 2023 provides data on the global ophthalmic viscoelastic devices market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The ophthalmic viscoelastic devices market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.